NDC 51662-1455

AMIDATE(TM) ETOMIDATE

Amidate(tm) Etomidate

AMIDATE(TM) ETOMIDATE is a Intravenous Injection, Solution in the Human Prescription Drug category. It is labeled and distributed by Hf Acquisition Co Llc, Dba Healthfirst. The primary component is Etomidate.

• Product ID: 51662-1455_99847797-99ec-40d4-e053-2995a90a972a
• NDC: 51662-1455
• Product Type: Human Prescription Drug
• Proprietary Name: AMIDATE(TM) ETOMIDATE
• Generic Name: Amidate(tm) Etomidate
• Dosage Form: Injection, Solution
• Route of Administration: INTRAVENOUS
• Marketing Start Date: 2019-12-12
• Marketing Category: NDA / NDA
• Application Number: NDA018227
• Labeler Name: HF Acquisition Co LLC, DBA HealthFirst
• Substance Name: ETOMIDATE
• Active Ingredient Strength: 2 mg/mL
• Pharm Classes: General Anesthesia [PE],General Anesthetic [EPC]
• NDC Exclude Flag: N
• Listing Certified Through: 2020-12-31

Packaging

NDC 51662-1455-1

20 mL in 1 VIAL, SINGLE-DOSE (51662-1455-1)

• Marketing Start Date: 2019-12-12
• NDC Exclude Flag: N
• Sample Package?: N

NDC SPL Data Element Entries

NDC 51662-1455-1 [51662145501]

AMIDATE(TM) ETOMIDATE INJECTION, SOLUTION

• Marketing Category: NDA
• Application Number: NDA018227
• Product Type: HUMAN PRESCRIPTION DRUG
• Marketing Start Date: 2019-12-12

Drug Details

Active Ingredients

Ingredient	Strength
ETOMIDATE	2 mg/mL

Pharmacological Class

• General Anesthesia [PE]
• General Anesthetic [EPC]

NDC Crossover Matching brand name "AMIDATE(TM) ETOMIDATE" or generic name "Amidate(tm) Etomidate"

NDC	Brand Name	Generic Name
51662-1455	AMIDATE(TM) ETOMIDATE	AMIDATE(TM) ETOMIDATE
51662-1459	AMIDATE(TM) ETOMIDATE	AMIDATE(TM) ETOMIDATE